AGAllison Gomes

Allison Gomes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Allison Gomes has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Jane Ziegler

    Department of Clinical and Preventive Nutrition Sciences School of Health Professions at Rutgers University Newark New Jersey USA

    3 shared publications
  • Craig Lapin

    Pulmonary Division Connecticut Children's Medical Center Hartford Connecticut USA

    2 shared publications
  • Laura Byham-Gray

    Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Newark, NJ 07107, USA

    2 shared publications
  • Laura Byham‐Gray

    School of Health Professions Rutgers University Newark New Jersey USA

    2 shared publications
  • Anca Cunningham

    Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Newark, NJ 07102, USA

    1 shared publication
  • Anna Dcn Parker

    Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Newark, New Jersey

    1 shared publication

Latest Publications

  • Open Access

    Early enteral nutrition with mothers’ own milk, donor human milk, or a combination of both on neonatal feeding milestones: a cross-sectional study

    by Lyssa Lamport, Hamed Samavat, Allison Gomes, Melanie Newkirk, Laura Byham-Gray, Jane Ziegler

    Objective: To evaluate the association between early enteral nutrition (EN) with mothers’ own milk (MOM), donor human milk (DHM), or a combination on time to human milk (HM) fortification, time to full EN, and parenteral nutrition (PN) duration. Study design: Cross-sectional retrospective chart review of 359 preterm infants grouped by HM type. A generalized linear model was used to analyze the impact of HM type on days to HM fortification, full EN, and PN duration. Results: Median gestational age was 28.9 (27.1–30.4) weeks; mean birth weight was 1060.5 ± 248.9 g. HM fortification occurred at 5.0 (4.0–7.0) days, full EN at 9.0 (7.0–11.0) days, and PN duration was 10.0 (9.0–13.0) days. No significant differences were found across HM groups for HM fortification ( P = 0.787), full EN ( P = 0.724), or PN days ( P = 0.71). Conclusion: Early feeding with MOM, DHM, or both does not delay achievement of neonatal feeding milestones in preterm infants.

  • Disability-Related Educational Content in Nutrition and Dietetic Programs: An Exploratory Study.

    by Wendy Medunick, Allison Gomes, Joachim Sackey, Laura Byham-Gray, Jane Ziegler

    Background: Health disparities experienced by people with disabilities (PWD) are partly attributed to inadequate knowledge, training, confidence and competence regarding disabilities among health professionals. While registered dietitian nutritionists (RDNs) are key members of the healthcare team, it is unclear how pre-professional nutrition and dietetics (ND) programs prepare future RDNs to care for PWD. This study examined the status of disability-related education within ND programs in the United States. Methods: A descriptive cross-sectional electronic survey was distributed to 570 directors of accredited ND programs. The survey, which adapted questions from a previously validated instrument and published studies, included questions assessing disability-related content, teaching methods, resources and potential barriers to inclusion within the curriculum. All data were analyzed using descriptive statistics. Results: Participants (n=64) were mostly female and between the ages of 34 and 68 years. The most common disability specific content included were patient-centered care, cultural humility and implicit bias training and an interdisciplinary approach to care. Most programs included relevant aspects of nutrition assessment for PWD, however, the types of disabilities included varied across programs. Common teaching methods were lectures, case studies, journal articles and clinical placements. A lack of faculty knowledge and expertise in disability education was identified as a potential barrier. Conclusion: ND programs include varying amounts and types of disability-related content, suggesting that entry-level RDNs may not be adequately prepared to address the nutritional needs of PWD. Programs should be evaluated to identify areas for improvement in disability-related content and to assess student understanding of these topics.

  • Open Access

    Effects of Green Tea Extract Supplementation on Inflammatory Cytokines Among Postmenopausal Women with Overweight or Obesity—A Secondary Analysis of a Randomized Controlled Trial

    by Anca Cunningham, Allison Gomes, Lingqiong Meng, Sue Shapses, Laura Byham-Gray, Hamed Samavat

    Background: Excess adiposity induces low-grade inflammation, including increased C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Green tea contains epigallocatechin gallate (EGCG), with anti-inflammatory potential. EGCG metabolism is influenced by individual variations in catechol-O-methyltransferase (COMT) genotypes. Objectives: To evaluate the effect of green tea extract (GTE) supplementation on circulating inflammatory cytokines among postmenopausal women with overweight or obesity and differing COMT genotypes. Methods: This study is a secondary analysis of a random subset (N = 97) from the Minnesota Green Tea Trial (MGTT), a randomized double-blinded placebo-controlled trial. The intervention was a high-dose GTE supplement (843 ± 44 mg EGCG/day) or placebo for 1 year. Serum CRP, TNF-α, and IL-6 were measured at 0, 6, and 12 months. Absolute changes in inflammatory cytokines from baseline to month 12 were evaluated using linear mixed-effects models adjusted for age, body mass index (BMI), smoking history, physical activity, and vitamin supplement use. Results: The changes from month 0 to month 12 were not statistically different between the groups for any of the inflammatory cytokines measured. The overall treatment effect was not statistically significant for CRP (p = 0.24), IL-6 (p = 0.59), TNF-α (p = 0.36), nor for the interaction between treatment group and time (all Ps > 0.40). There was no significant interaction between treatment group and COMT genotype for the stated markers. Conclusions: A high-dose GTE supplement consumed daily for one year did not significantly decrease inflammatory cytokines among postmenopausal women with overweight or obesity. The COMT genotype did not modify the effects of GTE supplementation on inflammatory cytokines. Future studies with a larger sample size among those at high risk of systemic inflammation are warranted.


  • Open Access

    The effect of oral nutrition supplements and appetite stimulants on weight status among pediatric cancer patients: A systematic review

    by Corey Hawes, Alison Gomes, Laura Byham‐Gray, Stephanie Henderson

    The objective of this study was to identify the use and impact of oral nutrition supplements (ONSs) and appetite stimulants on weight status among pediatric patients diagnosed with malignancy. We performed a literature search of trials using Medline PubMed, CINAHL, Web of Science Core Collection, Scopus, and Cochrane Database of Systematic Reviews and included all prospective studies except review articles and case‐reports/series that assessed ONSs or appetite stimulants among patients (0–20 years old) diagnosed with a pediatric malignancy. Databases were searched through May 17, 2022. There were six trials included with three studies related to ONS and the remaining on appetite stimulants. No studies that compared both ONS and appetite stimulants were found. To assess quality, we used the Risk of Bias in Nonrandomized Studies of Interventions and the Revised Cochrane Risk of Bias Tool for Randomized Trials depending on the study design. The studies all had pediatric patients diagnosed with a variety of malignancy types. All studies demonstrated improvement of weight status in the treatment group across various malignancy types. However, none of the studies addressed nutrition intakes outside of ONS consumption, compliance to ONSs, or frequency of ONS use. Despite the short durations (3–6 months) and significant differences in the timing of intervention initiation (ONS or appetite stimulants), these treatment modalities can improve weight status. Further research is needed to identify the best intervention for improving weight status.


  • The associations between pediatric weight status and cystic fibrosis‐related diabetes status and health‐related quality of life among children and young adults with cystic fibrosis: A systematic review

    by Allison Gomes, Rachael Patusco, Mei Chung, Margaret R. Dreker, Laura Byham‐Gray, Craig Lapin, Jane Ziegler

    Background: Cystic fibrosis (CF) is a life‐shortening genetic disease, yet life expectancy has recently increased, shifting the focus to disease management and health‐related quality of life (HRQoL). Identification of clinical factors, such as weight status and CF‐related diabetes (CFRD), that are associated with HRQoL can inform clinicians about the patient's health perception. The goal of this systematic review was two prong: identify the association of pediatric weight status and HRQoL and determine how CFRD status impacts HRQoL.Methods: A systematic review of published research was conducted following the methodology in the Cochrane Handbook on Systematic Reviews for Interventional Studies. Results were reported according to the Preferred Reporting Items for Systematic Review and Meta‐Analyses. Risk of bias was assessed using the National Heart Lung & Blood Institute tool. A meta‐analysis was not performed due to variability of the inclusion/exclusion criteria, differences in outcome reporting, and insufficient primary outcome data to pool.Results: Nine studies met inclusion criteria (n = 6 explored weight status and n = 3 studied CFRD), for a total of 1585 subjects (CFRD cases = 87). Pediatric weight status was positively associated with HRQoL, most commonly the Body Image and Eating Disturbance domains. CFRD was negatively associated with HRQoL, specifically the Treatment Burden and Weight domains.Conclusions: Based on the limited data available, improved pediatric weight status appears to increase HRQoL while a CFRD diagnosis appears to decrease HRQoL. More research is needed to fully understand the role of these clinical factors on HRQoL, especially with life expectancy increasing among those with CF.


  • Weight Gain and Growth After Fundoplication in the Pediatric Patient: A Case Report in the Pediatric Patient With Cystic Fibrosis and Literature Review

    by Allison Gomes, Craig Lapin, Jane Ziegler

    Gastroesophageal reflux (GER) is common among infants, but when symptoms become troublesome, that is defined as gastroesophageal reflux disease (GERD). Making a diagnosis of GERD is difficult because there is no gold standard. GERD can be especially problematic for infants with cystic fibrosis (CF). There are signs and symptoms (ie, malnutrition, recurring aspiration pneumonias, refusal to eat, wheezing, coughing, and asthma) in addition to invasive and noninvasive methods used to determine a diagnosis. The treatments for GERD span from nonpharmacological to surgical, with a laparoscopic Nissen fundoplication being the gold standard of surgical intervention. Although surgical interventions have been demonstrated to reduce symptoms associated with GERD, there is little known about the weight/growth-related outcomes. This case report discusses an infant with CF and GERD requiring multiple interventions and ultimately a laparoscopic Nissen fundoplication and the weight changes from presurgery to postsurgery. The case report is expanded upon with a structured literature review of fundoplication and growth studies. There were 4 available studies that assessed changes in weight/growth before and after fundoplication among children with GERD. Because of the heterogeneity of the nutrition outcomes used, the weight/growth benefits after fundoplication are unclear at this time. Further research in needed to assess the nutrition outcomes among patients with GERD requiring fundoplication.


  • The Association Between Vitamin D Status and Pulmonary Function in Pediatric Patients With Cystic Fibrosis

    by Allison Ms Gomes, Anna Dcn Parker, Rena Dcn Zelig

    Sufficient vitamin D levels play an essential role in bone health and, more recently, in pulmonary function. Achieving sufficient vitamin D levels is challenging, especially among individuals with malabsorptive diseases, such as cystic fibrosis (CF). Cystic fibrosis is characterized by a progressive loss of pulmonary function and fat malabsorption, increasing the risk for vitamin D deficiency. After reviewing the literature for pediatric patients with CF, the association between vitamin D status and pulmonary function remains unclear. More studies are needed to evaluate whether adequate vitamin D status can assist in maintaining pulmonary function and slowing disease progression.

  • Association Between Fat‐Free Mass and Pulmonary Function in Patients With Cystic Fibrosis: A Narrative Review

    by Allison Gomes, Deborah Hutcheon, Jane Ziegler

    The association between body mass index (BMI) and pulmonary function in patients with cystic fibrosis (CF) is well established, yet BMI as the sole indicator of nutrition status fails to assess body composition, specifically fat‐free mass (FFM). Reduced FFM is a characteristic of undernutrition and is associated with decreased pulmonary function. A critical review of the literature was undertaken to explore available evidence on the use of FFM derived from dual‐energy X‐ray absorptiometry (DXA), compared with BMI, to assess pulmonary function and thereby nutrition status in patients with CF. Four cross‐sectional studies that met predefined inclusion and exclusion criteria were selected for review. Based on the evidence reviewed, reduced FFM was associated with reduced pulmonary function in both children and adults with CF. FFM was reduced among patients who may not otherwise be identified as at nutrition risk based on BMI alone. FFM, as compared with BMI, appears to be a better indicator of pulmonary function and nutrition status in patients with CF. Although future research is needed to identify and determine FFM measurements that are associated with improved pulmonary function and nutrition status in patients with CF, these findings highlight the potential value and clinical utility of using FFM measurements derived from DXA among patients with CF. Together, FFM and BMI may provide a more comprehensive picture of nutrition status during the nutrition assessment of the patient with CF.


  • The Impact of Weight Status on Health-Related Quality of Life and Body Image in Adults With Cystic Fibrosis

    by Allison Ms Gomes, Pamela EdD Rothpletz-Puglia, Laura PhD Matarese, Jane Dcn Ziegler

    The increased life expectancy seen in patients with cystic fibrosis (CF) shifts the focus of nutrition interventions from supporting survival to improving quality of life. The aim of this narrative review is to explore the importance of weight status and health-related quality of life in adults with CF. This review also identifies research supporting the differences in body image based on sex, which impacts an individual's weight status and health-related quality of life. Based on the literature, the CF care team should incorporate body image screening into clinical practice to optimize weight status and increase health-related quality of life in the adult with CF.